Immune-modulating effects of alpha-1 antitrypsin

Biological Chemistry

Volumn 395, Issue 10, 2014, Pages 1187-1193

  Ehlers, Mario R ^a  

^a Immune Tolerance Network   (United States)

Author keywords

Apoptosis; Autoimmunity; Diabetes; Inflammation; Protease; Transplantation

Indexed keywords

ALPHA 1 ANTITRYPSIN; IMMUNOLOGIC FACTOR;

ADAPTIVE IMMUNITY; ALLOTRANSPLANTATION; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNITY; AUTOTRANSPLANTATION; CONFERENCE PAPER; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; RHEUMATOID ARTHRITIS; ANIMAL; APOPTOSIS; CHEMISTRY; DRUG EFFECTS; IMMUNOLOGY; INFLAMMATION; MOUSE; PATHOLOGY; STRUCTURE ACTIVITY RELATION;

ADAPTIVE IMMUNITY; ALPHA 1-ANTITRYPSIN; ANIMALS; APOPTOSIS; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; INFLAMMATION; MICE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84908877404     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2014-0161     Document Type: Conference Paper

References (46)

1. Bergin, D.A., Reeves, E.P., Meleady, P., Henry, M., McElvaney, O.J., Carroll, T.P., Condron, C., Chotirmall, S.H., Clynes, M., O'Neill, S.J., et al. (2010). α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. J. Clin. Invest. 120, 4236-4250.
2. Bergin, D.A., Reeves, E.P., Hurley, K., Wolfe, R., Jameel, R., Fitzgerald, S., and McElvaney, N.G. (2014). The circulating proteinase inhibitor α-1 antitrypsin regulates neutrophil degranulation and autoimmunity. Sci. Transl. Med. 6, 217ra1.
3. Bucurenci, N., Blake, D.R., Chidwick, K., and Winyard, P.G. (1992). Inhibition of neutrophil superoxide production by human plasma α1-antitrypsin. FEBS 300, 21-24.
4. Churg, A., Dai, J., Zay, K., Karsan, A., Hendricks, R., Yee, C., Martin, R., MacKenzie, R., Xie, C., Zhang, L., et al. (2001). Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab. Invest. 81, 1119-1131.
5. Crystal, R.G. (1990). α-1 Antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J. Clin. Invest. 85, 1343-1352.
6. Daemen, M.A.R.C., Heemskerk, V.H., van't Veer, C., Denecker, G., Wolfs, T.G.A.M., Vandenabeele, P., and Buurman, W.A. (2000). Functional protection by acute phase proteins α1-acid glycoprotein and α1-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation. Circulation 102, 1420-1426.
7. Ehlers, M.R. and Nepom, G.T. (2012). Immune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experience. Rev. Diabet. Stud. 9, 359-371.
8. Elliott, P.R., Abrahams, J.P., and Lomas, D.A. (1998). Wild-type α1- antitrypsin is in the canonical inhibitory conformation. J. Mol. Med. 275, 419-425.
9. FDA (U.S. Food and Drug Administration) (2013). Heterogeneity of alpha1-proteinase inhibitor (human) products. http://www.fda. gov/biologicsbloodvaccines/bloodbloodproducts/questionsaboutblood/ ucm127718.htm.
10. Grimstein, C., Choi, Y.K., Wasserfall, C.H., Satoh, M., Atkinson, M.A., Brantly, M.L., Campbell-Thompson, M., and Song, S. (2011). Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model. J. Transl. Med. 9, 21.
11. Huber, R. and Carrell, R.W. (1989). Implications of the three-dimensional structure of α1-antitrypsin for structure and function of serpins. Biochemistry 28, 8951-8966.
12. Ikari, Y., Mulvihill, E., and Schwartz, S.M. (2001). α1-Proteinase inhibitor, α1-antichymotrypsin, and α2-macroglobulin are the antiapoptotic factors of vascular smooth muscle cells. J. Biol. Chem. 276, 11798-11803.
13. Janciauskiene, S., Larsson, S., Larsson, P., Virtala, R., Jansson, L., and Stevens, T. (2004a). Inhibition of lipopolysaccharide-mediated human monocyte activation, in vitro, by α1- antitrypsin. Biochem. Biophys. Res. Commun. 321, 592-600.
14. Janciauskiene, S., Zelvyte, I., Larsson, L., and Stevens, T. (2004b). Divergent effects of α1-antitrypsin on neutrophil activation, in vitro. Biochem. Biophys. Res. Commun. 315, 288-296.
15. Janciauskiene, S., Nita, I.M., and Stevens, T. (2007). α1-Antitrypsin, old dog, new tricks. α1-Antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. J. Biol. Chem. 282, 8573-8582.
16. Janciauskiene, S., Bals, R., Koczulla, R., Vogelmeier, C., Kohnlein, T., and Welte, T. (2011). The discovery of α1-antitrypsin and its role in health and disease. Resp. Med. 105, 1129-1139.
17. Kalis, M., Kumar, R., Janciauskiene, S., Salehi, A., and Cilio, C.M. (2010). Alpha 1-antitrypsin enhances insulin secretion and prevents cytokine-mediated apoptosis in pancreatic β-cells. Islets 2, 185-189.
18. Knappstein, S., Ide, T., Schmidt, M.A., and Heusipp, G. (2004). α1-Antitrypsin binds to and interferes with functionality of EspB from atypical and typical enteropathogenic Escherichia coli strains. Infect. Immun. 72, 4344-4350.
19. Koulmanda, M., Bhasin, M., Hoffman, L., Fan, Z., Qipo, A., Shi, H., Bonner-Weir, S., Putheti, P., Degauque, N., Libermann, T.A., et al. (2008). Curative and β cell regenerative effects of α1- antitrypsin treatment in autoimmune diabetic NOD mice. Proc. Natl. Acad. Sci. USA 105, 16242-16247.
20. Koulmanda, M., Bhasin, M., Fan, Z., Hanidziar, D., Goel, N., Putheti, P., Movahedi, B., Libermann, T.A., and Strom, T.B. (2012). Alpha 1-antitrypsin reduces inflammation and enhances mouse pancreatic islet transplant survival. Proc. Natl. Acad. Sci. USA 109, 15443-15448.
21. Lewis, E.C. (2012). Expanding the clinical indications for α1-antitrypsin therapy. Mol. Med. 18, 957-970.
22. Lewis, E.C., Shapiro, L., Bowers, O.J., and Dinarello, C.A. (2005). α1-Antitrypsin monotherapy prolongs islet allograft survival in mice. Proc. Natl. Acad. Sci. USA 102, 12153-12158.
23. Lewis, E.C., Mizrahi, M., Toledano, M., DeFelice, N., Wright, J.L., Churg, A., Shapiro, L., and Dinarello, C.A. (2008). α1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc. Natl. Acad. Sci. USA 105, 16236-16241.
24. Libert, C., Van Molle, W., Brouckaert, P., and Fiers, W. (1996). α1-Antitrypsin inhibits the lethal response to TNF in mice. J. Immunol. 157, 5126-5129.
25. Lu, Y., Tang, M., Wasserfall, C., Kou, Z., Campbell-Thompson, M., Gardemann, T., Crawford, J., Atkinson, M., and Song, S. (2006). α1-Antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice. Hum. Gene Ther. 17, 625-634.
26. Ma, H., Lu, Y., Li, H., Campbell-Thompson, M., Parker, M., Wasserfall, C., Haller, M., Brantly, M., Schatz, D., Atkinson, M., et al. (2010). Intradermal α1-antitrypsin therapy avoids fatal anaphylaxis, prevents type 1 diabetes and reverses hyperglycemia in the NOD mouse model of the disease. Diabetologia 53, 2198-2204.
27. Marcondes, A.M., Li, X., Tabellini, L., Bartenstein, M., Kabacka, J., Sale, G.E., Hansen, J.A., Dinarello, C.A., and Deeg, H.J. (2011). Inhibition of IL-32 activation by α1-antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model. Blood 118, 5031-5039.
28. Mizrahi, M., Cal, P., Rosenthal, M., Ochayon, D., Shahaf, G., Kaner, Z., Kachker, P., and Lewis, E.C. (2013). Human ±1- antitrypsin modifies B-lymphocyte responses during allograft transplantation. Immunology 140, 362-373.
29. Nagai, A., Aoshiba, K., Ishihara, Y., Inano, H., Sakamoto, K., Yamaguchi, E., Kagawa, J., and Takizawa, T. (1992) Administration of alpha-1-proteinase inhibitor ameliorates bleomycininduced pulmonary fibrosis in hamsters. Am. Rev. Respir. Dis. 145, 651-656.
30. Nita, I., Hollander, C., Westin, U., and Janciauskiene, S.M. (2005). Prolastin, a pharmaceutical preparation of purified human αI-antitrypsin, blocks endotoxin-mediated cytokine release. Resp. Res. 6, 12.
31. Nita, I., Serapinas, D., and Janciauskiene, S.M. (2007). α1- Antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro. Int. J. Biochem. Cell Biol. 39, 1165-1176.
32. Ozeri, E., Mizrahi, M., Sharaf, G., and Lewis, E.C. (2012). α-1 Antitrypsin promotes semimature, IL-10-producing and readily migrating tolerogenic dendritic cells. J. Immunol. 189, 146-153.
33. Petrache, I., Fijalkowska, I., Medler, T.R., Skirball, J., Cruz, P., Zhen, L., Petrache, H.I., Flotte, T.R., and Tuder, R.M. (2006). α-1 Antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am. J. Pathol. 169, 1155-1166.
34. Pott, G.B., Chan, E.D., Dinarello, C.A., and Shapiro, L. (2009). α-1-Antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J. Leukoc. Biol. 85, 886-895.
35. Sandström, C.S., Novoradovskaya, N., Cilio, C.M., Piitulainen, E., Sveger, T., and Janciauskiene, S. (2008). Endotoxin receptor CD14 in PiZ α-I-antitrypsin deficiency individuals. Resp. Res. 9, 34.
36. Shpacovitch, V., Feld, M., Hollenberg, M.D., Luger, T.A., and Steinhoff, M. (2008). Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. J. Leukoc. Biol. 83, 1309-1322.
37. Song, S., Goudy, K., Campbell-Thompson, M., Wasserfall, C., Scott- Jorgensen, M., Wang, J., Tang, Q., Crawford, J.M., Ellis, T.M., Atkinson, M.A., et al. (2004). Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice. Gene Ther. 11, 181-186.
38. Strom, T.B. (2005). Saving islets from allograft rejection. Proc. Natl. Acad. Sci. USA 102, 12651-12652.
39. Subramaniyam, D., Glader, P., von Wachenfeldt, K., Burneckiene, J., Stevens, T., and Janciauskiene, S. (2006). C-36 peptide, a degradation product of α1-antitrypsin, modulates human monocyte activation through LPS signaling pathways. Int. J. Biochem. Cell Biol. 38, 563-575.
40. Subramanian, S., Shahaf, G., Ozeri, E., Miller, L.M., Vandenbark, A.A., Lewis, E.C., and Offner, H. (2011). Sustained expression of circulating human alpha-1 antitrypsin reduces inflammation, increases CD4+FoxP3+ Treg cell population and prevents signs of experimental autoimmune encephalomyelitis in mice. Metab. Brain Dis. 26, 107-113.
41. Tawara, I., Sun, Y., Lewis, E.C., Toubai, T., Evers, R., Nieves, E., Azam, T., Dinarello, C.A., and Reddy, P. (2012). Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation. Proc. Natl. Acad. Sci. USA 109, 564-569.
42. Tilg, H., Vannier, E., Vachino, G., Dinarello, C.A., and Mier, J.W. (1993). Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1β synthesis by human peripheral blood mononuclear cells. J. Exp. Med. 178, 1629-1636.
43. Tumen, J., Meyrick, B., Berry, L., and Brigham, K.L. (1988). Antiproteinases protect cultured lung endothelial cells from endotoxin injury. J. Appl. Physiol. 65, 835-843.
44. Van Molle, W., Libert, C., Fiers, W., and Brouckaert, P. (1997). α1-Acid glycoprotein and α1-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice. J. Immunol. 159, 3555-3564.
45. Yoshida, K., Suzuki, Y., Saito, A., Fukuda, K., Hamanishi, C., and Munakata, H. (2005). Aggrecanase-1 (ADAMTS-4) interacts with α1-antitrypsin. Biochim. Biophys. Acta 1725, 152-159.
46. Zhang, B., Lu, Y., Campbell-Thompson, M., Spencer, T., Wasserfall, C., Atkinson, M., and Song, S. (2007). α1-Antitrypsin protects β-cells from apoptosis. Diabetes 56, 1316-1323.